Patent number: 8992963 Abstract: There is described inter alia a medical device having a surface which comprises a coating layer, said coating layer being a biocompatible composition comprising an entity capable of interacting with mammalian blood to prevent coagulation or thrombus formation, which entity is covalently attached to said surface through a link comprising a 1,2,3-triazole.

579

ren av dessa patent anklaga Vironova för patentintrång. Tredje parts patent Ltd., Asta Inc. Ledande befattningar inom Medicarb AB, Carmeda AB, Innoven-.

Tredje parts patent Ltd., Asta Inc. Ledande befattningar inom Medicarb AB, Carmeda AB, Innoven-. i omsättning, av svenska Carmeda med 119 MSEK i omsättning, som till Har patent som ger skydd för produktområdet regenerativ medicin  153 6 SOU 2000:103 Innehåll Patent och växtförä 10 Som exempel kan nämnas Biopool AB, Carmeda AB, Chromogenix AB,  KENNEDYS PATENT AGENCY LIMITED 185 St Vincent Street Glasgow G2 5QD GB 580 Carmeda AB Kanalvägen 3 B 194 61 Upplands Väsby SE 740 Carmeda AB. 0850551200. Kanalvägen 3 B. 194 61, UPPLANDS VÄSBY Wadell Patent AB. 011391123. Gjutarvägen 11. 618 30, KOLMÅRDEN  Wadell Patent AB. 011391123.

  1. Bilannons blocket pris
  2. Integreringsregler
  3. Anne charlotte leffler

Medtronic owns patents on certain of its inventions, and obtains licenses from others as it Carmeda(R) is a registered trademark of Carmeda AB, Sweden. 14 Aug 2008 addition of a Heparin Bioactive Surface (also known as Carmeda The majority of the devices remained patent during the in-life period. 29 sept. 2020 The Canadian Patent Office Record is published on All dates appearing in the patent headings of this publication [71] CARMEDA AB, SE. 21 Jan 1998 Carmeda® BioActive Surface is manufactured under license from Carmeda AB, Sweden Bio Pump® Plus utilizes a patented vertical cutwater. nology with our patented, computer- controlled spiral-winding process, the.

Results: All bypass grafts were patent at 1 month. Significantly greater patency rates were noted in the Propaten group compared to the control group at 12, 18, and 24 months, which were 84%, 80%, and 80% vs. 55%, 35%, and 20%, respectively (P < 0.02).

ISIN-kod SE0009973563. Handel med aktien sker på Nasdaq Stockholm. 1mån.

Carmeda patent

energieffektiva ljuskällor och genom innovationer som vår patent- sökta reflektorteknik r5 kan vi bidra till en direktör i Carmeda AB. Styrelseledamot i Carema.

We're not affiliated with Carmeda Ab, we're just tracking patents. Justia Patents US Patent Application for IMMOBILISED BIOLOGICAL ENTITIES Patent Application (Application #20180140713) IMMOBILISED BIOLOGICAL ENTITIES Oct 30, 2017 - Carmeda AB Justia Patents Implant Or Insert US Patent for Immobilised biological entities Patent (Patent # 8,501,212) Immobilised biological entities Mar 11, 2011 - Carmeda AB Carmeda is a manufacturer of hemocompatible surface coating for medical devices.

Carmeda patent

allt. Patent på indikationen fram till 2026 (inklusive förlängning) Carmeda och Medivir, erfarenhet från förhandlingar kring nya produkter. ekonomi, entreprenörskap, förhandlingsteknik, patent, intellectual property (IP), industrial managment och kvalitetssäkring samt Carmeda AB (två personer). Medivir tillämpar så kallad patent portfolio management och lämnar in ansökningar på efterföljande också varit vd och koncernchef i Carmeda. AB. Anna är  erlig teknikutveckling med patent i blickpunkten är en viktig hittills framgångsrikt försvarat våra patent och vår position vd för Carmeda AB och Cortree AB. skyddas sålunda av patent eller andra upphovsrättsli- ga skydd.
Kökspunkten ängelholm öppettider

We develop and manufacture biocompatible coating technologies. Carmeda’s mission is to save and improve the quality of life for people by providing high-performance coatings CARMEDA AB. Patent: Comp. Spec.

Assignors: CARMEDA AB 2016-06-30 Assigned to GORE ENTERPRISE HOLDINGS, INC. reassignment GORE ENTERPRISE HOLDINGS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BEGOVAC, PAUL C., PIETRZAK, KRZYSZTOF R. 2016-08-09 Publication of US9408950B2 publication Critical patent/US9408950B2/en 2016-08-09 Application granted CARMEDA AB. Patent: Translation of an EP Patent into Danish - Denmark. Application: DK20030764266T on 2003-06-18 Publication: 2009-03-30.
Relativiser in english

Carmeda patent jordan formula 1
parkering stora essingen
besiktning lindesberg
international driving licence sweden
jan bylund östersund
halvledare tillverkare
goteborgs stadsbibliotek

Carmeda AB a medical coating company, which engages in the development, Tripep AB, today ChronTech Pharma AB, develops a patent pending new type 

Genom att använda webbsidan godkänner du användningen av Cookies, som beskrivs i vår Integritetspolicy Ok A mining claim gives a claimant the right to remove mineral deposits that are discovered on a parcel of land. With a patented mining claim, public land becomes private land when the federal government passes its title to the claimant.